E
Elysium Therapeutics, Inc.
Profile managed by Bizz IdElysium Therapeutics
Estados Unidos
11-50 employees
Description
Biopharmaceutical company developing the O2P™ platform (oral hydrocodone prodrug with bifunctional technology), designed to release therapeutic opioid levels in the intestine and reduce overdose risk. Additional platforms: XpiRx (forced expiration) and SOOPR (opioid overdose prevention and rescue).